Bukwang Pharm, Stem Cell Theme Rises 7.02% Up

On the 4th, the stem cell theme rose by 3.16% compared to the previous day, showing strength, while Bukwang Pharm, which is attracting attention as a related stock, surged by 7.02% compared to the previous day. Bukwang Pharm is known as a manufacturer of pharmaceuticals and quasi-drugs (such as toothpaste).

[Graph] Major stock price changes in the stem cell theme



According to provisional data compiled at 11:06, foreigners are selling -29,000 shares of Bukwang Pharm, resulting in a large net sell-off by foreigners.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Bukwang Pharm’s quant financial score is 16.36 points, with higher stability and profitability scores than the average of other stocks related to stem cells, ranking 11th within the theme. This indicates that Bukwang Pharm’s ability to respond to changes in domestic and international economic environments and its efficient profit-generating capacity are better compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.